10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
The interplay between non-communicable diseases (NCDs) and infections presents unique challenges in public health. People with underlying NCDs are more vulnerable to infections, and infections can further complicate the management of chronic conditions, leading to higher morbidity and mortality. The growing prevalence of both NCDs and infections requires a holistic approach to healthcare, where addressing risk factors such as poor diet, lack of exercise, and inadequate sanitation becomes critical. In managing non-communicable diseases and infections, healthcare providers must focus on prevention, early diagnosis, and tailored treatments that consider the complexities of co-existing chronic and infectious conditions. This integrated approach can improve the quality of life for individuals and reduce the overall healthcare burden.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Carbapenemase-producing multidrug resistance of gram negative bacilli causing bacteremia at the general hospital of Mexico during the Covid-19 pandemic
Silvia Giono, Instituto Politecnico Nacional, Mexico
Title : The largest histamine poisoning outbreak in Brazil: An experience report from a one health perspective in Fernando de Noronha
Camila Ferro, Fundacao Oswaldo Cruz (Fiocruz), Brazil
Title : Combating antimicrobial resistance in sub-Saharan Africa: Advancing one health strategies for sustainable infectious disease control
Ugorji Miracle Enyinnaya, Greatlink Pharmaceutical, Nigeria